Search

Co and Contra-Regulation of Glycosylated Proteins in Three Distinct Regions of Schizophrenics Brain

Journal: Current Proteomics
Volume: 13 Issue: 3 Year: 2016 Page: 187-195
Author(s): Ayesha Khan, Nikhat Ahmed, Beena Hasan, Shamim Mushtaq

In Vivo MR Imaging of the Flow of the Brain Interstitial Fluid

Journal: Neuroscience and Biomedical Engineering (Discontinued)
Volume: 4 Issue: 4 Year: 2016 Page: 225-229
Author(s): Bin Liu,Cunjing Zhang,Yuliang Li

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 10 Year: 2016 Page: 1305-1311
Author(s): Juan Camilo Jurado-Coronel,Marco Avila-Rodriguez,Francisco Capani,Janneth Gonzalez,Valentina Echeverria Moran,George E. Barreto

Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View

Journal: Current Neuropharmacology
Volume: 14 Issue: 3 Year: 2016 Page: 260-271
Author(s): Roberta Filograna,Mariano Beltramini,Luigi Bubacco,Marco Bisaglia

An Update on Human Stem Cell-Based Therapy in Parkinson's Disease

Journal: Current Stem Cell Research & Therapy
Volume: 11 Issue: 7 Year: 2016 Page: 561-568
Author(s): Clara González,Sonia Bonilla,Ana Isabel Flores,Eva Cano,Isabel Liste

Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15 Issue: 3 Year: 2016 Page: 292-300
Author(s): Juan C. Jurado-Coronel,Marco Ávila-Rodriguez,Valentina Echeverria,Oscar Alejandro Hidalgo,Janneth Gonzalez,Gjumrakch Aliev,George E. Barreto

PAX6 expression may be protective against dopaminergic cell loss in Parkinson’s disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15 Issue: 1 Year: 2016 Page: 73-79
Author(s): Meghan G. Thomas,Caitlyn Welch,Leah Stone,Peter Allan,Roger A. Barker,Robert B. White

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 2 Year: 2016 Page: 238-246
Author(s): Amir Sarrafchi, Mahmoud Bahmani, Hedayatollah Shirzad, Mahmoud Rafieian-Kopaei

Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues

Journal: Current Drug Delivery
Volume: 13 Issue: 8 Year: 2016 Page: 1205-1221
Author(s): Kamla Pathak,Nida Akhtar

Parkinson’s Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors

Journal: Current Drug Metabolism
Volume: 17 Issue: 5 Year: 2016 Page: 513-518
Author(s): Riccardo Montioli,Carla B. Voltattorni,Mariarita Bertoldi